Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mallinckrodt Plc (MNK)

Mallinckrodt Plc (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Shares of MNK Down 63.6% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on April 18th, 2019 at $18.66. In approximately 3 months, Mallinckrodt has returned 63.60% as of today's recent price of $6.79.

MNK : 6.69 (-1.62%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mallinckrodt plc - MNK

Pomerantz LLP is investigating claims on behalf of investors of Mallinckrodt plc ("Mallinckrodt" or the "Company") (NYSE: MNK). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

MNK : 6.69 (-1.62%)
Watch for Mallinckrodt to Potentially Rebound After Falling 3.03% Yesterday

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $6.12 to a high of $7.13. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $6.75 on...

MNK : 6.69 (-1.62%)
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, and Silence Therapeutics plc (LON: SLN), a leader in the discovery, development and delivery of novel RNA1 interference (RNAi) therapeutics...

MNK : 6.69 (-1.62%)
SILENCE THERAPEUTICS AND MALLINCKRODT ANNOUNCE COLLABORATION TO DEVELOP AND COMMERCIALIZE RNAi THERAPEUTICS FOR COMPLEMENT-MEDIATED DISEASES

SILENCE THERAPEUTICS AND MALLINCKRODT ANNOUNCE COLLABORATION TO DEVELOP AND COMMERCIALIZE RNAi THERAPEUTICS FOR COMPLEMENT-MEDIATED DISEASES

MNK : 6.69 (-1.62%)
SLNCF : 2.0800 (+9.47%)
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, and Silence Therapeutics plc (LON: SLN), a leader in the discovery, development and delivery of novel RNA2 interference (RNAi) therapeutics...

MNK : 6.69 (-1.62%)
SLNCF : 2.0800 (+9.47%)
After Yesterday's Decline of 7.20%, Mallinckrodt Offers Investors Better Value

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $7.29 to a high of $8.29. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $8.10 on...

MNK : 6.69 (-1.62%)
Mallinckrodt Halts Phase 2B Trial Investigating the Use of Acthar® Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS)

Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced that it is permanently discontinuing its Phase 2B study designed to assess the efficacy and safety of...

MNK : 6.69 (-1.62%)
Shares of MNK Down 54.9% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on April 18th, 2019 at $18.65. In approximately 3 months, Mallinckrodt has returned 54.86% as of today's recent price of $8.42.

MNK : 6.69 (-1.62%)
Will Mallinckrodt (MNK) Beat Estimates Again in Its Next Earnings Report?

Mallinckrodt (MNK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

MNK : 6.69 (-1.62%)
Shares of Medicines Comp Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (MDCO , MNK , NKTR , MYL , LCI )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

MDCO : 36.36 (-0.19%)
MNK : 6.69 (-1.62%)
NKTR : 32.09 (-0.77%)
Mallinckrodt Set to Possibly Rebound After Yesterday's Selloff of 3.82%

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $8.31 to a high of $9.13. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $8.62 on...

MNK : 6.69 (-1.62%)
Mallinckrodt to Report Earnings Results for Second Quarter 2019

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that it will report second quarter 2019 earnings results for the period ending June 28, 2019 on Tuesday, Aug. 6, 2019.

MNK : 6.69 (-1.62%)
Mallinckrodt (MNK) Outpaces Stock Market Gains: What You Should Know

Mallinckrodt (MNK) closed the most recent trading day at $9.18, moving +1.89% from the previous trading session.

MNK : 6.69 (-1.62%)
50.9% Return Seen to Date on SmarTrend Mallinckrodt Call (MNK)

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on April 18th, 2019 at $18.66. In approximately 2 months, Mallinckrodt has returned 50.90% as of today's recent price of $9.16.

MNK : 6.69 (-1.62%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (MNK , NKTR , LCI , MYL , OMER )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

LCI : 6.78 (-19.48%)
MNK : 6.69 (-1.62%)
NKTR : 32.09 (-0.77%)
Relatively Good Performance Detected in Shares of Lannett Co Inc in the Pharmaceuticals Industry (LCI , MDCO , MNK , RVNC , SUPN )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

LCI : 6.78 (-19.48%)
MDCO : 36.36 (-0.19%)
MNK : 6.69 (-1.62%)
Thinking about trading options or stock in Alibaba, Coupa Software, Electronic Arts, Mallinckrodt, or Pfizer?

InvestorsObserver issues critical PriceWatch Alerts for BABA, COUP, EA, MNK, and PFE.

BABA : 178.09 (+2.35%)
COUP : 141.03 (-2.85%)
MNK : 6.69 (-1.62%)
EA : 88.22 (+0.09%)
PFE : 43.09 (+0.63%)
Mallinckrodt Achieves 50 Percent Enrollment for Phase 2B Trial Investigating the Use of Acthar® Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS)

Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today confirmed it has achieved 50 percent patient enrollment in the company's Phase 2B study designed to assess the...

MNK : 6.69 (-1.62%)
After Yesterday's Decline of 6.37%, Mallinckrodt Offers Investors Better Value

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $8.93 to a high of $9.23. Yesterday, the shares fell 6.4%, which took the trading range below the 3-day low of $9.01 on...

MNK : 6.69 (-1.62%)

Van Meerten Stock Picks

Eldorado Gold
My Stock Pick of the Day belongs to the gold producer Eldorado Gold (EGO).
EGO -0.32
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar